Skip to content

Clinical trials

Phase 3 Major Depressive Disorder trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Country / region: Sweden Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20071
20102
20112
20123
20131
20202
20212
20222
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC5
Karolinska Institutet3
AstraZeneca2
Eli Lilly and Company2
Intra-Cellular Therapies, Inc.2
Neumora Therapeutics, Inc.2
Sanofi2
H. Lundbeck A/S1
Janssen-Cilag International NV1
Neurocrine Biosciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder23
Anxiety Disorders3
Sleep Initiation and Maintenance Disorders3
Stress Disorders, Traumatic3
Anhedonia2
Depressive Disorder1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.